Tag Archives: WD

Hot Value Stocks To Buy For 2021

Merck KGaA (FRA:MRK) has been given an average rating of “Hold” by the twenty-one ratings firms that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and seven have given a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is €98.74 ($114.81).

Several analysts have recently commented on MRK shares. Commerzbank set a €100.00 ($116.28) target price on Merck KGaA and gave the company a “buy” rating in a research note on Wednesday, November 14th. Sanford C. Bernstein set a €105.00 ($122.09) target price on Merck KGaA and gave the company a “buy” rating in a research note on Tuesday, November 13th. Kepler Capital Markets set a €108.00 ($125.58) target price on Merck KGaA and gave the company a “buy” rating in a research note on Thursday, November 15th. Credit Suisse Group set a €110.00 ($127.91) target price on Merck KGaA and gave the company a “buy” rating in a research note on Thursday, November 15th. Finally, Berenberg Bank set a €102.00 ($118.60) target price on Merck KGaA and gave the company a “buy” rating in a research note on Friday, November 23rd.

Hot Value Stocks To Buy For 2021: Becton, Dickinson and Company(BDX)

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The companys BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; generic prefilled injectables; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation, and diagnostics equipment and consumables; and consumables for patient monitoring and anesthesia delivery. Its Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and womens health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Advisors’ Opinion:

  • [By Stephan Byrd]

    In other Becton Dickinson and news, CEO Vincent A. Forlenza sold 11,340 shares of the firm’s stock in a transaction dated Monday, February 25th. The stock was sold at an average price of $250.40, for a total value of $2,839,536.00. Following the transaction, the chief executive officer now directly owns 227,250 shares of the company’s stock, valued at $56,903,400. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Ribo Alberto Mas sold 4,808 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $255.03, for a total value of $1,226,184.24. Following the completion of the transaction, the executive vice president now directly owns 22,476 shares in the company, valued at $5,732,054.28. The disclosure for this sale can be found here. Insiders have sold 19,271 shares of company stock worth $4,862,179 over the last ninety days. 0.12% of the stock is currently owned by insiders.

    ILLEGAL ACTIVITY WARNING: “Becton Dickinson and Co (BDX) Position Lifted by CIBC Asset Management Inc” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at www.tickerreport.com/banking-finance/4205866/becton-dickinson-and-co-bdx-position-lifted-by-cibc-asset-management-inc.html.

    Becton Dickinson and Company Profile

  • [By Max Byerly]

    Stevens First Principles Investment Advisors decreased its stake in shares of Becton Dickinson and Co (NYSE:BDX) by 1.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,750 shares of the medical instruments supplier’s stock after selling 250 shares during the quarter. Becton Dickinson and comprises about 2.6% of Stevens First Principles Investment Advisors’ portfolio, making the stock its 13th biggest holding. Stevens First Principles Investment Advisors’ holdings in Becton Dickinson and were worth $3,774,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Joseph Griffin]

    Levin Capital Strategies L.P. lowered its position in Becton Dickinson and Co (NYSE:BDX) by 0.3% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 49,800 shares of the medical instruments supplier’s stock after selling 150 shares during the quarter. Levin Capital Strategies L.P.’s holdings in Becton Dickinson and were worth $11,221,000 at the end of the most recent quarter.

  • [By Brian Orelli]

    Becton, Dickinson and Company’s (NYSE:BDX) first fiscal quarter of 2019 will be the last one with wacky year-over-year comparisons because of the addition of C.R. Bard. Fortunately, as it’s done for the last three quarters, the company was kind enough to present the comparisons on a comparable currency-neutral basis as if the companies had been together in the year-ago quarter.

Hot Value Stocks To Buy For 2021: Walker & Dunlop, Inc.(WD)

Walker & Dunlop, Inc., incorporated on July 29, 2010, is a holding company, which conducts all of its operations through Walker & Dunlop, LLC. The Company is a provider of commercial real estate financial services in the United States, with a primary focus on multifamily lending. Walker & Dunlop, LLC is its operating company. The Company originates, sells, and services a range of multifamily and other commercial real estate financing products, including Multifamily Finance, Federal Housing Administration (FHA) Finance, Capital Markets, and Proprietary Capital. The Company’s clients are developers and owners of commercial real estate. It originates and sells loans through the programs of the Federal National Mortgage Association (Fannie Mae), the Federal Home Loan Mortgage Corporation (Freddie Mac, and together with Fannie Mae, the government-sponsored enterprises (GSEs)), the Government National Mortgage Association (Ginnie Mae) and the Federal Housing Administration, a division of the United States Department of Housing and Urban Development (together with Ginnie Mae, HUD).

The Company retains servicing rights and asset management responsibilities on nearly all loans that it originates for GSE and HUD programs. It is approved as a Fannie Mae Delegated Underwriting and Servicing (DUS) lender across the nation, a Freddie Mac Program Plus lender in over 20 states and the District of Columbia, a Freddie Mac focused affordable housing seller/servicer, a HUD Multifamily Accelerated Processing (MAP) lender across the nation, a HUD Section 232 LEAN lender across the nation, and a Ginnie Mae issuer. It broker and service loans for a range of life insurance companies, commercial banks, commercial mortgage backed securities (CMBS) issuers, and other institutional investors, in which cases it does not fund the loan but rather act as a loan broker. It also originates and holds interim loans on its balance sheet and offers a CMBS platform. The Company focuses primarily on multifamily properties and of! fers a range of commercial real estate finance products to its customers, including first mortgage loans, second trust loans, supplemental financings, construction loans, mezzanine loans, and bridge/interim loans.

Multifamily Finance

The Company is a lender approved as a Freddie Mac Program Plus lender under, which it originates and sells to Freddie Mac multifamily, manufactured housing communities, student housing and healthcare loans, among others. Under the program, the Company submits its completed loan underwriting package to Freddie Mac and obtains Freddie Mac’s commitment to purchase the loan at a price after closing. The Company is also contracted by Fannie Mae to service all loans that it originates under the Fannie Mae DUS program.

FHA Finance

The Company provides construction and permanent loans to developers and owners of multifamily housing, affordable housing, seniors housing and healthcare facilities. The Company submits its completed loan underwriting package to HUD and obtains HUD’s approval to originate the loan. HUD-insured loans are placed in single loan pools, which back Ginnie Mae securities.

Capital Markets

The Company serves as an intermediary in the placement of commercial real estate debt between institutional sources of capital, such as life insurance companies, investment banks, commercial banks, pension funds, CMBS issuers and other institutional investors, and owners of all types of commercial real estate. The Company advises on capital structure, develops the financing package, facilitates negotiations between its client and institutional sources of capital, coordinates due diligence, and assists in closing the transaction. In these instances, it does not underwrite or fund the loan and does not retain any interest in the loan. In cases where it does not fund the loan, it acts as a loan broker and services some of these loans.

Proprietary Capital

The Company conducts its! Propriet! ary Capital business either using its own balance sheet. It also operates the CMBS Partnership through a partnership agreement with an institutional investor. The Company makes investments side by side with its partnership investors and serves as the manager or general manager of the partnership. In its capacity as manager or general manager, it leverages the invested capital to originate, hold, and service commercial real estate debt, including interim loans and CMBS. It offers interim loans that provide floating-rate and interest-only debt for terms of till approximately three years to borrowers seeking to acquire or reposition multifamily properties that do not qualify for permanent financing. The Company finances and underwrites the loans originated through the Interim Program. In addition, it services and asset-manages loans originated through the Interim Program, with the focus of providing permanent financing on the properties.

In addition to its CMBS product offering through its Capital Markets platform, it offers CMBS executions through its CMBS Program. The CMBS partnership offers financing through a CMBS platform for all commercial property types across the United States. The property types include multifamily, hospitality, retail, office, industrial, and other commercial real estate. The loans in the CMBS Partnership are selected, funded, and underwritten by the CMBS Partnership. It performs the servicing for loans originated through the CMBS Program.

Investment Sales Brokerage Services

The Company offer investment sales brokerage services to owners and developers of multifamily properties that are seeking to sell the properties. Its services are offered primarily in the eastern United States, with a focus in the Southeast. The Company, through Walker & Dunlop Investment Sales, LLC (WDIS), conducts its investment sales operations.

Direct Loan Originators and Correspondent Network

The Company originates loans directly through lo! an origin! ators operating over 20 offices. Its loan originators collect and analyze financial and property information, assist the borrowers in submitting information required to complete a loan application, and helps the borrower in closing the loan. The Company has correspondent agreements with over 20 independently owned mortgage banking companies, with which it has relationships for GSE and HUD loan originations. The Company’s correspondents assist it in evaluating loans, including pre-screening the borrowers, coordinating due diligence, and providing market intelligence.

Underwriting and Risk Management

The Company uses various tools to manage its Fannie Mae risk-sharing exposure. These tools include an underwriting and approval process, evaluating, and modifying its underwriting criteria given the underlying multifamily housing market fundamentals, limiting its geographic, borrower and principal exposures, and using modified risk-sharing under the Fannie Mae DUS program.

The Company’s underwriting process begins with a review of suitability for its investors and a detailed review of the borrower, principals, and the property. It reviews a borrower’s financial statements for manageable net worth and liquidity requirements, as well as credit and criminal background checks. It also reviews a borrower’s and principals’ operating track record, including evaluating the performance of other properties owned by the applicable borrower and principals. It also considers the borrower’s and principals’ bankruptcy and foreclosure history. It reviews the fundamental value and credit profile of the underlying property, including an analysis of regional economic trends, appraisals of the property, and reviews of historical and prospective financials. Third-party vendors are engaged for appraisals, engineering reports, environmental reports, flood certification reports, zoning reports, and credit reports.

Servicing and Asset Management

The Company services all! loans th! at it originates for the GSEs, HUD, and its proprietary capital products and some of the loans it broker for institutional investors, primarily life insurance companies. It is an approved servicer for Fannie Mae, Freddie Mac, and HUD loans. Its servicing function includes loan servicing and asset management activities, such as carrying out all cashiering functions relating to the loan, including providing monthly billing statements to the borrower and collecting and applying payments on the loan; administering reserve and escrow funds for repairs, tenant improvements, taxes and insurance; obtaining and analyzing financial statements of the borrower and performing periodic property inspections; preparing and providing periodic reports and remittances to the GSEs, investors, master servicers, or other designated persons, and administering lien filings. It also outsources some of its servicing activities to a subservicer.

Advisors’ Opinion:

  • [By Lou Whiteman]

    Shares of Walker & Dunlop (NYSE:WD) surged 16.1% in February, according to data fromS&P Global Market Intelligence, after the real estate loan originator produced better-than-expected fourth-quarter results and provided an optimistic outlook for 2019.

  • [By Ethan Ryder]

    Walker & Dunlop, Inc. (NYSE:WD) – Equities research analysts at Wedbush raised their Q1 2019 earnings estimates for shares of Walker & Dunlop in a report released on Monday, February 11th. Wedbush analyst H. Coffey now forecasts that the financial services provider will post earnings of $1.05 per share for the quarter, up from their previous forecast of $0.99. Wedbush has a “Outperform” rating and a $58.00 price objective on the stock. Wedbush also issued estimates for Walker & Dunlop’s Q2 2019 earnings at $1.26 EPS, Q3 2019 earnings at $1.53 EPS, Q4 2019 earnings at $1.56 EPS, FY2019 earnings at $5.40 EPS and FY2020 earnings at $5.95 EPS.

  • [By Motley Fool Transcribing]

    Walker & Dunlop (NYSE:WD) Q4 2018 Earnings Conference CallFeb. 6, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Hot Value Stocks To Buy For 2021: New York Community Bancorp, Inc.(NYCB)

New York Community Bancorp, Inc., incorporated on July 16, 1993, is a multi-bank holding company. The Company operates through its subsidiaries, New York Community Bank (the Community Bank) and New York Commercial Bank (the Commercial Bank) (collectively, the Banks). The Company’s operations are divided into two segments: Banking Operations and Residential Mortgage Banking. The Banking Operations segment serves consumers and businesses by offering and servicing a range of loan and deposit products and other financial services. The Residential Mortgage Banking segment originates, aggregates, sells and services one- to four-family mortgage loans. Mortgage loan products consist of agency-conforming fixed- and adjustable-rate loans and, to a lesser extent, jumbo loans, for the purpose of purchasing or refinancing one- to four-family homes. The Community Bank is a chartered savings bank with approximately 230 branches that operates through over seven local divisions. The Community Bank is a producer of multi-family loans in New York City. The Commercial Bank is a chartered commercial bank with approximately 30 branches in Manhattan, Queens, Brooklyn, Westchester County and Long Island, including approximately 20 that operate under the name, Atlantic Bank. The Commercial Bank offers around the clock banking online, mobile banking and banking by phone. The Company also serves its customers through approximately three connected Websites: www.myNYCB.com, www.NewYorkCommercialBank.com and www.NYCBfamily.com.

Lending Activities

The Company’s principal asset is multi-family loans. Its loan portfolio consists of over three components: covered loans, non-covered loans held for sale and non-covered loans held for investment. The Company originates commercial real estate loans, most of which are collateralized by income-producing properties, such as office buildings, retail centers, mixed-use buildings and multi-tenanted light industrial properties that are located in New York City and on Lo! ng Island. The Company also originates acquisition, development, and construction (ADC) loans, and commercial and industrial (C&I) loans for investment. ADC loans are originated for multi-family and residential tract projects in New York City and on Long Island. C&I loans consist of asset-based loans, equipment loans and leases, and dealer floor-plan loans. C&I loans are made to small and mid-size businesses in Metro New York. Other C&I loans are made for working capital, business expansion, and the purchase of machinery and equipment. The Community Bank’s mortgage banking operation originates, aggregates and services one- to four-family loans. The Company’s total net loans are approximately $38.2 billion.

Investment Activities

The Company’s portfolio of securities available for sale consists of mortgage-related securities and other securities. Its mortgage-related securities include government-sponsored enterprise (GSE) certificates. Its other securities include municipal bonds, capital trust notes, preferred stock, and mutual funds and common stock, which consist of mutual funds. The Company’s total securities available for sale are approximately $204.26 million. The Company’s portfolio of securities held to maturity consists of mortgage-related securities, which include GSE certificates and GSE collateralized mortgage obligations (CMOs), and other securities, which include GSE debentures, corporate bond, municipal bonds and capital trust notes. The Company’s total securities held to maturity sale are approximately $6.1 billion.

Source of Funds

The Company’s funding sources for the payment of dividends, share repurchases and other corporate uses are dividends paid to the Company by the Banks; capital raised through the issuance of stock; funding raised through the issuance of debt instruments, and repayments of, and income from, investment securities. It offers various types of deposits, which include negotiable order of withdrawal (NOW) and money ma! rket acco! unts, savings accounts, certificates of deposit and non-interest-bearing accounts. The Company’s total deposits are approximately $28.4 billion. The Company’s borrowed funds include Federal Home Loan Bank (FHLB) advances, repurchase agreements, federal funds purchased and junior subordinated debentures.

Subsidiary Activities

The Community Bank has approximately 20 direct subsidiaries. Its direct subsidiaries include DHB Real Estate, LLC, Mt. Sinai Ventures, LLC, NYCB Mortgage Company, LLC, Realty Funding Company, LLC, NYCB Specialty Finance Company, LLC, Eagle Rock Investment Corp., Pacific Urban Renewal, Inc., Synergy Capital Investments, Inc., BSR 1400 Corp., Bellingham Corp., Blizzard Realty Corp., CFS Investments, Inc., Main Omni Realty Corp., NYB Realty Holding Company, LLC, O.B. Ventures, LLC, RCBK Mortgage Corp., RCSB Corporation, RSB Agency, Inc., Richmond Enterprises, Inc. and Roslyn National Mortgage Corporation. The Commercial Bank has approximately two direct subsidiaries, which are Beta Investments, Inc. and Gramercy Leasing Services, Inc. The Company also owns special business trusts that are formed for the purpose of issuing capital and common securities and investing the proceeds thereof in the junior subordinated debentures issued by it. It also has a non-banking subsidiary.

The Company competes with Astoria Financial Corporation.

Advisors’ Opinion:

  • [By Shane Hupp]

    ILLEGAL ACTIVITY NOTICE: “Comerica Bank Acquires 5,850 Shares of New York Community Bancorp, Inc. (NYCB)” was published by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at www.tickerreport.com/banking-finance/4180066/comerica-bank-acquires-5850-shares-of-new-york-community-bancorp-inc-nycb.html.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on New York Community Bancorp (NYCB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks To Own Right Now

A relative calm in global markets is at risk of ending abruptly as U.S. traders return from a market holiday to the sight of Italy’s government in full-blown political crisis.

Populist parties called for fresh elections after Italy’s president refused to endorse their choice of finance minister and appointed Carlo Cottarelli, a former International Monetary Fund official, as prime minister instead.

The political impasse in the third-largest euro-zone economy has sent yields on Italian two-year government bonds up by a whopping 202.4 basis points this month — the first monthly jump of over 100 basis points since May 2012, when Europe was enmeshed in the debt crisis that triggered existential questions about the single currency. While U.S. Treasury yields slipped some in Tuesday trading, broad measures of volatility remain a fraction of February highs.

#lazy-img-328105134:before{padding-top:56.25%;}

"The lack of an obvious solution to this impasse is troubling, especially given the size of Italy’s economy and debt stock," Morgan Stanley analysts including Andrew Sheets wrote in a note dated May 28. "Yet given the worry it’s causing, it’s notable what hasn’t moved."

Top 10 High Tech Stocks To Own Right Now: InterOil Corporation(IOC)

Advisors’ Opinion:

  • [By Shane Hupp]

    I/O Coin (CURRENCY:IOC) traded 26.1% higher against the US dollar during the one day period ending at 22:00 PM E.T. on August 17th. Over the last seven days, I/O Coin has traded up 50% against the US dollar. One I/O Coin coin can now be purchased for $0.39 or 0.00005901 BTC on exchanges. I/O Coin has a market capitalization of $6.55 million and approximately $14,268.00 worth of I/O Coin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    Media headlines about InterOil (NYSE:IOC) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. InterOil earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news articles about the oil and gas company an impact score of 45.5148763796823 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 High Tech Stocks To Own Right Now: Koss Corporation(KOSS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
    CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
    Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
    Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
    Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
    Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
    Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
    Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
    Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

     

  • [By Lisa Levin] Gainers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
    Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
    Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
    CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
    TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
    Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
    Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday.

     

  • [By Money Morning Staff Reports]

    However, Seven Star’s gains are already on the books. After looking at last week’s top performing penny stocks, we’ll show you a penny stock on the verge of jumping over 70%…

    Penny Stock Current Share Price Last Week’s Gain
    Seven Stars Cloud Group Inc. (Nasdaq: SSC) $4.49 175.13%
    Alliance MMA Inc. (Nasdaq: AMMA) $0.37 121.05%
    India Globalization Capital Inc. (NYSE: IGC) $1.14 74.38%
    Obalon Therapeutics Inc. (Nasdaq: OBLN) $3.23 63.16%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.56 55.76%
    Atlanticus Holdings Corp. (Nasdaq: ATLC) $2.85 43.55%
    Research Frontiers Inc. (Nasdaq: REFR) $1.28 41.37%
    Koss Corp. (Nasdaq: KOSS) $4.08 41.28%
    GLG Life Tech Corp. (TSE: GLG) $0.88 33.90%
    Geron Corp. (Nasdaq: GERN) $4.76 32.40%

    While those gains are already in the book, you don’t have to miss out on the next penny stocks to soar.

Top 10 High Tech Stocks To Own Right Now: Unilever NV(UN)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    Procter & Gamble (NYSE:PG) and Unilever (NYSE:UL) (NYSE:UN) have long been the two companies that have most defined the household goods space, dominating categories like detergent, soap, deodorant, and condiments, to name only a few.

  • [By Shanthi Rexaline]

    Unilever NV (ADR) ADR (NYSE: UN) procures sustainable oils such as soy, sunflower and rapeseed oil for a host of its consumer products such as Hellmann's mayonnaise. It remains to be seen how the U.S.-China standoff will hurt its margins.

  • [By Joseph Griffin]

    Stepan (NYSE: SCL) and Unilever (NYSE:UN) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

  • [By Stephan Byrd]

    Guyasuta Investment Advisors Inc. raised its position in shares of Unilever NV (NYSE:UN) by 1.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 459,725 shares of the company’s stock after buying an additional 4,520 shares during the period. Unilever comprises about 2.9% of Guyasuta Investment Advisors Inc.’s holdings, making the stock its 9th largest holding. Guyasuta Investment Advisors Inc.’s holdings in Unilever were worth $25,616,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Unilever (NYSE:UN) has earned an average recommendation of “Hold” from the nine research firms that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company.

Top 10 High Tech Stocks To Own Right Now: Walker & Dunlop, Inc.(WD)

Advisors’ Opinion:

  • [By Dan Caplinger]

    For more than a decade, the real estate market has rebounded from the housing bust in the mid-2000s that led to the financial crisis. Since then, demand for both residential and commercial properties has been strong, and Walker & Dunlop (NYSE:WD) has capitalized by offering multiple methods of financing to real estate developers. Yet at long last, rising interest rates have started to raise concerns among real estate investors that the long bull market in the asset class could finally come to an end.

  • [By Ethan Ryder]

    Walker & Dunlop, Inc. (NYSE:WD) – Equities research analysts at Wedbush raised their Q1 2019 earnings estimates for shares of Walker & Dunlop in a report released on Monday, February 11th. Wedbush analyst H. Coffey now forecasts that the financial services provider will post earnings of $1.05 per share for the quarter, up from their previous forecast of $0.99. Wedbush has a “Outperform” rating and a $58.00 price objective on the stock. Wedbush also issued estimates for Walker & Dunlop’s Q2 2019 earnings at $1.26 EPS, Q3 2019 earnings at $1.53 EPS, Q4 2019 earnings at $1.56 EPS, FY2019 earnings at $5.40 EPS and FY2020 earnings at $5.95 EPS.

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Micron Technology (NASDAQ:MU), and Walker & Dunlop (NYSE:WD) actually have relatively low valuations. Here’s why these are three bargain stocks you can buy right now. 

  • [By Logan Wallace]

    Boston Partners increased its holdings in Walker & Dunlop, Inc. (NYSE:WD) by 3.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,495,943 shares of the financial services provider’s stock after buying an additional 45,657 shares during the period. Boston Partners owned about 4.82% of Walker & Dunlop worth $83,249,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 High Tech Stocks To Own Right Now: Imperial Oil Limited(IMO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Imperial Oil Ltd (NYSEAMERICAN:IMO) (TSE:IMO) saw a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 11,491,321 shares, an increase of 1.1% from the May 31st total of 11,363,187 shares. Based on an average trading volume of 400,912 shares, the days-to-cover ratio is presently 28.7 days.

  • [By Shane Hupp]

    Swiss National Bank cut its position in shares of Imperial Oil (NYSEAMERICAN:IMO) (TSE:IMO) by 6.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,066,300 shares of the energy company’s stock after selling 76,100 shares during the period. Swiss National Bank owned approximately 0.13% of Imperial Oil worth $28,203,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Citadel Advisors LLC purchased a new stake in shares of Imperial Oil Ltd (NYSEAMERICAN:IMO) (TSE:IMO) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 44,728 shares of the energy company’s stock, valued at approximately $1,487,000.

Top 10 High Tech Stocks To Own Right Now: 1-800 FLOWERS.COM Inc.(FLWS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on 1-800-Flowers.Com (FLWS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    1-800-Flowers.Com (NASDAQ:FLWS)‘s stock had its “buy” rating restated by analysts at Benchmark in a research note issued on Wednesday, Marketbeat.com reports. They presently have a $16.00 price objective on the specialty retailer’s stock, up from their previous price objective of $14.00. Benchmark’s price objective would suggest a potential upside of 26.28% from the company’s previous close.

  • [By Motley Fool Transcribers]

    1-800-Flowers.com Inc (NASDAQ:FLWS)Q4 2018 Earnings Conference CallAug. 23, 2018, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 High Tech Stocks To Own Right Now: Prudential Public Limited Company(PUK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Prudential Public Limited (NYSE:PUK) has earned a consensus recommendation of “Hold” from the six analysts that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company.

  • [By Ethan Ryder]

    Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

  • [By Ethan Ryder]

    ValuEngine lowered shares of Prudential (NYSE:PUK) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning.

    Several other analysts have also recently issued reports on the stock. Zacks Investment Research upgraded shares of Prudential from a hold rating to a buy rating and set a $57.00 target price on the stock in a research note on Tuesday, March 27th. Berenberg Bank cut shares of Prudential from a hold rating to a sell rating in a research note on Thursday, March 29th. Finally, Citigroup cut shares of Prudential from a buy rating to a neutral rating in a research note on Wednesday, April 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The stock currently has an average rating of Hold and an average price target of $57.00.

  • [By Stephan Byrd]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Prudential alerts:

    Zacks Investment Research Lowers Prudential (PUK) to Hold (americanbankingnews.com) Financial wellness program popularity rises among employers, up 63 percentage points in two years (markets.financialcontent.com) FY2018 EPS Estimates for Prudential (PUK) Reduced by Jefferies Group (americanbankingnews.com) Jefferies Group Weighs in on Prudential’s FY2020 Earnings (PUK) (americanbankingnews.com) ValuEngine Downgrades Prudential (PUK) to Hold (americanbankingnews.com)

    Shares of PUK stock traded down $0.02 during trading on Tuesday, hitting $51.56. 141,455 shares of the stock traded hands, compared to its average volume of 198,097. The firm has a market cap of $66.49 billion, a PE ratio of 13.79, a PEG ratio of 1.34 and a beta of 1.55. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.03 and a current ratio of 0.03. Prudential has a 52-week low of $44.49 and a 52-week high of $55.36.

Top 10 High Tech Stocks To Own Right Now: ThyssenKrupp AG (TYEKF)

Advisors’ Opinion:

  • [By ]

    United Technologies’ Otis division manufactures and services elevators, escalators, and other people moving devices. The business is reasonably attractive since there is a fair degree of concentration. Four major companies, Kone Oyj (OTCPK:KNYJF) (OTCPK:KNYJY), ThyssenKrupp (OTCPK:TYEKF) (OTCPK:TKAMY), Schindler (OTCPK:SHLAF) (OTC:SHNDY), and Otis, account for over 50% market share. The main long-term drivers of the industry are urbanization. As you might guess, elevator demand is strongest in dense urban environments where almost every building is multi-story.

Top 10 High Tech Stocks To Own Right Now: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Ultragenyx Pharmaceutical (NASDAQ:RARE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ultragenyx launched its second drug, Crysvita, in the United States to treat X-linked hypophosphatemia (XLH) in April. We are optimistic on the drug’s uptake. The drug was also approved in the EU in February on a conditional basis. In May, the company announced positive phase II data from the drug in pediatric setting, but according to the FDA those were not sufficient to support an NDA. Thus, the company is in discussions with FDA and EMA, which would provide further clarity regarding whether an additional study would be required for the approval. The company also remains focused on its two-gene therapy programs — DTX301 for ornithine transcarbamylase deficiency and DTX401 for glycogen storage disease type Ia. However, developmental or regulatory setbacks could result in higher operating expenses and the need for additional capital. Loss estimates have narrowed ahead of  Q3 earnings release.”

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ultragenyx Pharmaceutical (RARE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is expected to report Phase 2 data from all its tumor-induced osteomalacia patients. Shares of Ultragenyx closed Friday at $76.87, in a 52-week range of $41.67 to $86.10 and with a consensus analyst target of $68.74.

  • [By Shane Hupp]

    These are some of the media headlines that may have effected Accern’s scoring:

    Get Ultragenyx Pharmaceutical alerts:

    Burosumab Improves Outcomes in Children with XLH in Phase 2 Trial (raredr.com) RARE Stock Is on the Verge of Breaking Out Toward Higher Prices (profitconfidential.com) Burosumab may benefit children with X-linked hypophosphatemia (medicalxpress.com) A Look Inside the Quant Data For Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE) (parkcitycaller.com) Ultragenyx Pharmaceutical Inc. (RARE)- Stock in the Trader’s Radar (nasdaqfortune.com)

    A number of research firms have recently weighed in on RARE. ValuEngine raised Ultragenyx Pharmaceutical from a “hold” rating to a “buy” rating in a report on Saturday. BidaskClub raised Ultragenyx Pharmaceutical from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 19th. Barclays raised Ultragenyx Pharmaceutical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $62.00 to $74.00 in a report on Friday, May 11th. Goldman Sachs Group began coverage on Ultragenyx Pharmaceutical in a report on Thursday, May 10th. They set a “neutral” rating and a $63.00 target price for the company. Finally, Zacks Investment Research downgraded Ultragenyx Pharmaceutical from a “hold” rating to a “sell” rating in a report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $70.06.

  • [By Motley Fool Transcribers]

    Ultragenyx Pharmaceutical Inc  (NASDAQ:RARE)Q4 2018 Earnings Conference CallFeb. 19, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) from a hold rating to a buy rating in a report released on Monday.

    A number of other brokerages have also recently weighed in on RARE. JPMorgan Chase restated an overweight rating and issued a $66.00 price objective (down from $68.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. Evercore ISI upgraded shares of Ultragenyx Pharmaceutical from an in-line rating to an outperform rating in a research note on Monday, January 22nd. Stifel Nicolaus restated a buy rating and issued a $74.00 price objective (down from $85.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. ValuEngine upgraded shares of Ultragenyx Pharmaceutical from a sell rating to a hold rating in a research note on Wednesday, April 4th. Finally, Wedbush reiterated a positive rating and set a $71.00 target price (up from $64.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, April 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Ultragenyx Pharmaceutical presently has a consensus rating of Buy and an average price target of $69.76.

Top 10 High Tech Stocks To Own Right Now: GWG Holdings, Inc(GWGH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Here are some of the news articles that may have effected Accern Sentiment’s analysis:

    Get GWG alerts:

    Critical Review: Citizens (CIA) vs. GWG (GWGH) (americanbankingnews.com) (Watch) Zibanejad scores in Sweden’s win over Russia (sny.tv) GWG Holdings’ (GWGH) CEO Jon Sabes on Q1 2018 Results – Earnings Call Transcript (msn.com) Edited Transcript of GWGH earnings conference call or presentation 14-May-18 8:30pm GMT (finance.yahoo.com) DWWA judge profile: Davide Buongiorno (decanter.com)

    A number of equities research analysts recently commented on the company. Zacks Investment Research raised GWG from a “hold” rating to a “buy” rating and set a $9.25 price target for the company in a research report on Wednesday, April 11th. ValuEngine lowered GWG from a “hold” rating to a “sell” rating in a research report on Monday, May 14th. Finally, Maxim Group reaffirmed a “buy” rating and set a $14.00 target price on shares of GWG in a research report on Tuesday, January 23rd.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on GWG (GWGH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 High Tech Stocks To Buy Right Now

The fact that gaming is no longer just gaming continues to benefit esports stocks. Esports, or competitions centered on video gaming, has reached new heights in popularity. Since Activision (NASDAQ:ATVI) created its Overwatch League for competitive gaming, esports have increased in popularity.

Over 360 million watched streamed video of the League of Legends competition. Since then, Arlington, Texas — already home to both the Dallas Cowboys and the Texas Rangers — will construct another sporting facility as it builds the largest arena in the country dedicated to esports. Further, the International Olympic Committee (IOC) may approve esports as a competition starting with the 2024 Olympic Games.

Such a trend affects stocks across the tech landscape. Not only are gaming companies helped, other firms also derive a considerable benefit. Many point to the stocks that dominate American video gaming, namely Activision, Electronic Arts (NASDAQ:EA), and Take-Two Interactive (NASDAQ:TTWO) as obvious winners.

Top 5 High Tech Stocks To Buy Right Now: Western Asset Mortgage Capital Corporation(WMC)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine lowered shares of Western Asset Mortgage Capit (NYSE:WMC) from a buy rating to a hold rating in a research report report published on Wednesday.

  • [By Stephan Byrd]

    Lincoln National Corp acquired a new position in Western Asset Mortgage Capital Corp (NYSE:WMC) during the 2nd quarter, Holdings Channel reports. The fund acquired 11,000 shares of the financial services provider’s stock, valued at approximately $115,000.

Top 5 High Tech Stocks To Buy Right Now: Virtusa Corporation(VRTU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Virtusa Corporation (NASDAQ: VRTU) is projected to report quarterly earnings at $0.55 per share on revenue of $279.85 million.

    Kamada Ltd. (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $24.02 million.

  • [By Max Byerly]

    Virtusa (NASDAQ:VRTU) – Equities research analysts at SunTrust Banks issued their Q1 2020 earnings per share (EPS) estimates for shares of Virtusa in a report released on Wednesday, May 16th. SunTrust Banks analyst F. Atkins expects that the information technology services provider will post earnings of $0.33 per share for the quarter. SunTrust Banks currently has a “Hold” rating on the stock. SunTrust Banks also issued estimates for Virtusa’s Q2 2020 earnings at $0.46 EPS, Q3 2020 earnings at $0.56 EPS and Q4 2020 earnings at $0.60 EPS.

  • [By Max Byerly]

    Sei Investments Co. reduced its stake in Virtusa Co. (NASDAQ:VRTU) by 5.5% during the 1st quarter, HoldingsChannel reports. The fund owned 21,835 shares of the information technology services provider’s stock after selling 1,275 shares during the period. Sei Investments Co.’s holdings in Virtusa were worth $1,058,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Great Lakes Advisors LLC grew its holdings in shares of Virtusa (NASDAQ:VRTU) by 38.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 166,531 shares of the information technology services provider’s stock after buying an additional 45,860 shares during the quarter. Great Lakes Advisors LLC owned 0.57% of Virtusa worth $8,070,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Virtusa (NASDAQ:VRTU) had its target price lifted by equities research analysts at Wedbush from $60.00 to $70.00 in a research report issued to clients and investors on Friday. The brokerage currently has an “outperform” rating on the information technology services provider’s stock. Wedbush’s price target suggests a potential upside of 23.09% from the company’s current price.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Virtusa (VRTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 High Tech Stocks To Buy Right Now: Walker & Dunlop, Inc.(WD)

Advisors’ Opinion:

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Micron Technology (NASDAQ:MU), and Walker & Dunlop (NYSE:WD) actually have relatively low valuations. Here’s why these are three bargain stocks you can buy right now. 

  • [By Stephan Byrd]

    Walker & Dunlop (NYSE: WD) and Medallion Financial (NASDAQ:MFIN) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends.

  • [By Stephan Byrd]

    Walker & Dunlop, Inc. (NYSE:WD) shares were down 5.2% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings. The company traded as low as $52.74 and last traded at $56.18. Approximately 824,229 shares changed hands during mid-day trading, an increase of 265% from the average daily volume of 225,646 shares. The stock had previously closed at $59.26.

  • [By Ethan Ryder]

    Rhumbline Advisers lifted its holdings in Walker & Dunlop (NYSE:WD) by 1.5% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 66,236 shares of the financial services provider’s stock after purchasing an additional 961 shares during the period. Rhumbline Advisers owned approximately 0.22% of Walker & Dunlop worth $3,936,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Boston Partners increased its holdings in Walker & Dunlop, Inc. (NYSE:WD) by 3.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,495,943 shares of the financial services provider’s stock after buying an additional 45,657 shares during the period. Boston Partners owned about 4.82% of Walker & Dunlop worth $83,249,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Stephan Byrd]

    Assetmark Inc. boosted its holdings in Walker & Dunlop, Inc. (NYSE:WD) by 40,411.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,646 shares of the financial services provider’s stock after buying an additional 3,637 shares during the period. Assetmark Inc.’s holdings in Walker & Dunlop were worth $217,000 as of its most recent SEC filing.

Top 5 High Tech Stocks To Buy Right Now: FIRST REPUBLIC BANK(FRC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Barclays (NYSE:BCS) and First Republic Bank (NYSE:FRC) are both large-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations.

  • [By Motley Fool Transcription]

    First Republic Bank (NYSE:FRC)Q3 2018 Earnings Conference CallOct. 12, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Motley Fool Staff]

    First Republic Bank (NYSE:FRC) Q1 2018 Earnings Conference CallApril 13, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 High Tech Stocks To Buy Right Now: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Lexicon Pharmaceuticals (LXRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    Sanofi’s also awaiting an FDA decision on sotagliflozin, a drug it licensed from Lexicon Pharmaceuticals (NASDAQ:LXRX) in 2015 for $300 million up front, up to $430 million in development and regulatory milestones, up to $990 million in specified sales milestones, and tiered, escalating royalties ranging from low double-digit percentages to 40% of net sales. 

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c

Hot Low Price Stocks To Watch For 2019

Penny stocks those stocks that trade for low prices, often with share prices of less than a dollar per share are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.

Call them penny stocks, microcaps or OTC stocks; by any name, theyre bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, “How risky could it be?”

Plenty. Per the Securities and Exchange Commission: Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.

Hot Low Price Stocks To Watch For 2019: Magellan Midstream Partners L.P.(MMP)

Advisors’ Opinion:

  • [By Tyler Crowe]

    If you are an investor in Magellan Midstream Partners (NYSE:MMP), you aren’t in it for the thrills of rapid growth and skyrocketing stock prices. Instead, you’re probably looking for a consistent, reliable business that will continue to churn out cash. If that is the case, then this past quarter’s earnings report was right up your alley. By no means was it exciting, but it was another quarter of delivering consistent results.

  • [By Reuben Gregg Brewer]

    Kinder Morgan, Inc. (NYSE:KMI) is one of the largest midstream companies in North America, and it has major dividend plans between 2018 and 2020. By the end of that period, it expects to increase its dividend from $0.50 per share per year (in 2017) to $1.25. That’s huge dividend growth in a short period of time. But don’t get too enamored by that news; the dividend will still be lower than it was before the midstream oil and gas company’s 75% dividend cut in 2016. If you’re looking for dividend income in the midstream space, take a look at longtime dividend payers ONEOK, Inc. (NYSE:OKE) and Magellan Midstream Partners, L.P. (NYSE:MMP) instead.

  • [By ]

    That means pipelines are equally busy carrying all that raw crude into these refineries and then carrying out gasoline, diesel and other finished products. So you’d think these would be boon times for Magellan Midstream Partners (NYSE: MMP), which owns 10,000 miles of pipeline that connect with 50% of the nation’s refinery capacity.

  • [By Matthew DiLallo]

    Magellan Midstream Partners (NYSE:MMP) is one of the bestmaster limited partnerships (MLPs) around. The oil and refined products pipeline and storage company boasts one of the top credit ratings and financial profiles in the sector. As a result, the company’s 5.6%-yielding distribution is on rock-solid ground.

  • [By Tyler Crowe]

    Oil and gas investors have been through the wringer over the past few years. Even the most stable investments in this industry — pipelines, processing, and logistics — haven’t been spared. Case in point: Shares of Magellan Midstream Partners (NYSE:MMP) have declined 18% over the past three years despite the company posting consistent revenue and cash flow growth. To top it off, there has been a slew of regulatory and tax changes in recent months that will have a significant impact on this particular industry.

Hot Low Price Stocks To Watch For 2019: Knowles Corporation(KN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Knowles Corporation (NYSE: KN) got a boost, shooting up 15 percent to $12.83 as the company reported Q1 results.

    SVB Financial Group (NASDAQ: SIVB) shares were also up, gaining 19 percent to $305.90 following strong quarterly results.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
  • [By Joseph Griffin]

    These are some of the news articles that may have impacted Accern Sentiment’s scoring:

    Get Knowles alerts:

    Head to Head Contrast: Knowles (KN) vs. Sony (SNE) (americanbankingnews.com) Knowles (KN) Given Consensus Rating of “Hold” by Analysts (americanbankingnews.com) Four seniors nab scholarships from Siouxland Officials Association (siouxcityjournal.com) When is Who Dares Wins on BBC One tonight, how old is host Nick Knowles and how does the game show work? (thesun.co.uk) Local students learn the art of architecture (dailytidings.com)

    KN has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $17.00 price target (down from $20.00) on shares of Knowles in a research report on Thursday, February 8th. Zacks Investment Research lowered Knowles from a “hold” rating to a “sell” rating in a research report on Wednesday, February 14th. ValuEngine lowered Knowles from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. JPMorgan Chase lowered their price target on Knowles from $16.00 to $13.50 and set a “neutral” rating for the company in a research report on Tuesday, April 24th. Finally, Lake Street Capital lowered their price target on Knowles from $19.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, February 8th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $17.29.

  • [By Stephan Byrd]

    Sony (NYSE: SNE) and Knowles (NYSE:KN) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

Hot Low Price Stocks To Watch For 2019: Walker & Dunlop, Inc.(WD)

Advisors’ Opinion:

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Micron Technology (NASDAQ:MU), and Walker & Dunlop (NYSE:WD) actually have relatively low valuations. Here’s why these are three bargain stocks you can buy right now.

Hot Low Price Stocks To Watch For 2019: Tower International, Inc.(TOWR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Tower International (NYSE:TOWR) was downgraded by analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a report released on Wednesday.

Hot Low Price Stocks To Watch For 2019: DHI Group, Inc.(DHX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    DHI Group, Inc. (NYSE:DHX) – Analysts at B. Riley lifted their Q2 2018 earnings per share estimates for DHI Group in a research report issued to clients and investors on Wednesday, May 9th. B. Riley analyst K. Anderson now forecasts that the technology company will post earnings of $0.05 per share for the quarter, up from their prior estimate of $0.04. B. Riley currently has a “Hold” rating and a $2.00 target price on the stock. B. Riley also issued estimates for DHI Group’s Q4 2018 earnings at $0.07 EPS and FY2019 earnings at $0.15 EPS.

Hot Low Price Stocks To Watch For 2019: Seaspan Corporation(SSW)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

  • [By Matthew DiLallo]

    Shares of Seaspan Corporation (NYSE:SSW) rallied 15% last month thanks to a bullish analyst note.

    So what

    Seaspan’s stock bobbed around the flatline for most of April until an analyst at Deutsche Bank upgraded the containership leasing company from hold to buy toward the end of the month. What stood out was the $13 price target, which was 85% above the bank’s previous one of $7 a share. Driving that bullish view is the expectation that Seaspan’s ability to deleverage its balance sheet and increase the dividend would fuel substantial share price appreciation in the future.

  • [By ]

    Seaspan (SSW) : “No, this one has moved up too much.”

    Criticare Systems Inc (CMD) : “This stock has moved so much. I like Thermo Fisher Scientific (TMO) a little better.”

  • [By ]

    Cramer was bearish on Seaspan (SSW) , Symantec (SYMC) and Hi-Crush Partners (HCLP) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.